118.36
-1.11(-0.93%)
Currency In USD
| Previous Close | 119.47 |
| Open | 120 |
| Day High | 120 |
| Day Low | 117.4 |
| 52-Week High | 249.91 |
| 52-Week Low | 115.94 |
| Volume | 934,725 |
| Average Volume | 657,483 |
| Market Cap | 5.23B |
| PE | 36.64 |
| EPS | 3.23 |
| Moving Average 50 Days | 124.59 |
| Moving Average 200 Days | 170.54 |
| Change | -1.11 |
If you invested $1000 in Teleflex Incorporated (TFX) 10 years ago, it would be worth $917.66 as of July 01, 2025 at a share price of $118.36. Whereas If you bought $1000 worth of Teleflex Incorporated (TFX) shares 5 years ago, it would be worth $328.29 as of July 01, 2025 at a share price of $118.36.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
GlobeNewswire Inc.
Jun 12, 2025 10:30 AM GMT
WAYNE, Pa., June 12, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced findings from a new multinational study reporting efficacy of Arrow™ Chlorhexidine-Impregnated Centr
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month
GlobeNewswire Inc.
Jun 11, 2025 10:30 AM GMT
Timed with National Men’s Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men1—and encourages them to take control of their
Teleflex Publishes 2024 Global Impact Report
GlobeNewswire Inc.
May 19, 2025 10:30 AM GMT
Highlights Accomplishments and Sets Goals for Corporate Social Responsibility ProgramWAYNE, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published